115450.KQ
HLB Therapeutics Co.,Ltd.
KOE · Healthcare · Biotechnology · KR
KRW 2,050.00
+0.74%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 1.19x
- Price / sales
- 2.66x
- Price / cash flow
- -146.69x
Enterprise value
- Enterprise value
- KRW 224.4B
- EV / sales
- 3.47x
- EV / EBITDA
- -31.63x
- EV / EBIT
- -25.12x
- Market cap
- KRW 172.0B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026